| Laura Elizabeth Knutson, MD | |
|
1000 E Rosser Ave, Bismarck, ND 58501 | |
| (701) 712-4541 | |
| (701) 712-4191 |
| Full Name | Laura Elizabeth Knutson |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 10 Years |
| Location | 1000 E Rosser Ave, Bismarck, North Dakota |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174941264 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 15225 (North Dakota) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Innovis Health Llc | 9931298155 | 473 |
News Archive
They have found that prolactin, a pituitary hormone that normally stimulates breast development and milk production, initiates a new "signaling pathway" that may regulate the growth and survival of breast cancer cells.
A Wall Street Journal column published in May "hit the nail on the head: Medical liability reforms, including a cap on noneconomic damages, work," which raises the question of "why ... every state (and Congress)" has not "passed meaningful tort reform," American Medical Association Board Member J. James Rohack writes in a Journal letter to the editor.
Significant advances have taken place in the management of patients with advanced and metastatic non-small-cell lung cancer over the last 5 years. Traditionally, all advanced NSCLC patients were treated in a similar manner.
Patients who undergo elective total hip or total knee arthroplasty at hospitals with lower surgical volume had a higher risk of venous thromboembolism and mortality following the procedure.
Michael Croft, Ph.D., a researcher at the La Jolla Institute for Allergy & Immunology, has discovered a molecule's previously unknown role as a major trigger for airway remodeling, which impairs lung function, making the molecule a promising therapeutic target for chronic asthma, chronic obstructive pulmonary disease and several other lung conditions.
› Verified 7 days ago
| Entity Name | Mid Dakota Clinic, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275587826 PECOS PAC ID: 9638072895 Enrollment ID: O20040127001063 |
News Archive
They have found that prolactin, a pituitary hormone that normally stimulates breast development and milk production, initiates a new "signaling pathway" that may regulate the growth and survival of breast cancer cells.
A Wall Street Journal column published in May "hit the nail on the head: Medical liability reforms, including a cap on noneconomic damages, work," which raises the question of "why ... every state (and Congress)" has not "passed meaningful tort reform," American Medical Association Board Member J. James Rohack writes in a Journal letter to the editor.
Significant advances have taken place in the management of patients with advanced and metastatic non-small-cell lung cancer over the last 5 years. Traditionally, all advanced NSCLC patients were treated in a similar manner.
Patients who undergo elective total hip or total knee arthroplasty at hospitals with lower surgical volume had a higher risk of venous thromboembolism and mortality following the procedure.
Michael Croft, Ph.D., a researcher at the La Jolla Institute for Allergy & Immunology, has discovered a molecule's previously unknown role as a major trigger for airway remodeling, which impairs lung function, making the molecule a promising therapeutic target for chronic asthma, chronic obstructive pulmonary disease and several other lung conditions.
› Verified 7 days ago
| Entity Name | Innovis Health Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1215125463 PECOS PAC ID: 9931298155 Enrollment ID: O20071211000158 |
News Archive
They have found that prolactin, a pituitary hormone that normally stimulates breast development and milk production, initiates a new "signaling pathway" that may regulate the growth and survival of breast cancer cells.
A Wall Street Journal column published in May "hit the nail on the head: Medical liability reforms, including a cap on noneconomic damages, work," which raises the question of "why ... every state (and Congress)" has not "passed meaningful tort reform," American Medical Association Board Member J. James Rohack writes in a Journal letter to the editor.
Significant advances have taken place in the management of patients with advanced and metastatic non-small-cell lung cancer over the last 5 years. Traditionally, all advanced NSCLC patients were treated in a similar manner.
Patients who undergo elective total hip or total knee arthroplasty at hospitals with lower surgical volume had a higher risk of venous thromboembolism and mortality following the procedure.
Michael Croft, Ph.D., a researcher at the La Jolla Institute for Allergy & Immunology, has discovered a molecule's previously unknown role as a major trigger for airway remodeling, which impairs lung function, making the molecule a promising therapeutic target for chronic asthma, chronic obstructive pulmonary disease and several other lung conditions.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Laura Elizabeth Knutson, MD 1000 E Rosser Ave, Bismarck, ND 58501 Ph: (701) 712-4541 | Laura Elizabeth Knutson, MD 1000 E Rosser Ave, Bismarck, ND 58501 Ph: (701) 712-4541 |
News Archive
They have found that prolactin, a pituitary hormone that normally stimulates breast development and milk production, initiates a new "signaling pathway" that may regulate the growth and survival of breast cancer cells.
A Wall Street Journal column published in May "hit the nail on the head: Medical liability reforms, including a cap on noneconomic damages, work," which raises the question of "why ... every state (and Congress)" has not "passed meaningful tort reform," American Medical Association Board Member J. James Rohack writes in a Journal letter to the editor.
Significant advances have taken place in the management of patients with advanced and metastatic non-small-cell lung cancer over the last 5 years. Traditionally, all advanced NSCLC patients were treated in a similar manner.
Patients who undergo elective total hip or total knee arthroplasty at hospitals with lower surgical volume had a higher risk of venous thromboembolism and mortality following the procedure.
Michael Croft, Ph.D., a researcher at the La Jolla Institute for Allergy & Immunology, has discovered a molecule's previously unknown role as a major trigger for airway remodeling, which impairs lung function, making the molecule a promising therapeutic target for chronic asthma, chronic obstructive pulmonary disease and several other lung conditions.
› Verified 7 days ago
Rachel Marohl, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1000 E Rosser Ave, Bismarck, ND 58501 Phone: 701-712-4500 | |
Dr. Jessica D Sedevie, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 414 N 7th St, Bismarck, ND 58501 Phone: 701-323-5441 | |
Dr. Jerry M Obritsch, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1000 E Rosser Ave, Bismarck, ND 58501 Phone: 701-712-4500 Fax: 701-712-4098 | |
Dr. Peter L Klemin, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 414 N. 7th St., Medcenter One, Inc., Bismarck, ND 58501 Phone: 701-323-5870 Fax: 701-323-5869 | |
Peter A.u. Woodrow, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 414 N 7th St, Bismarck, ND 58501 Phone: 701-323-6543 Fax: 701-323-5709 | |
Dr. Shannon S Bradley, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 310 N 10th St, Bismarck, ND 58501 Phone: 701-530-6000 Fax: 701-530-6430 |